BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26153098)

  • 1. Arteriosclerosis and vascular calcification: causes, clinical assessment and therapy.
    Tölle M; Reshetnik A; Schuchardt M; Höhne M; van der Giet M
    Eur J Clin Invest; 2015 Sep; 45(9):976-85. PubMed ID: 26153098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vascular Calcification - Pathological Mechanism and Clinical Application - . Bisphosphonates for vascular calcification].
    Kurozumi A; Okada Y; Nakano K; Tanaka Y
    Clin Calcium; 2015 May; 25(5):723-8. PubMed ID: 25926576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular calcifications in chronic kidney disease: Potential therapeutic implications.
    Bover J; Ureña-Torres P; Górriz JL; Lloret MJ; da Silva I; Ruiz-García C; Chang P; Rodríguez M; Ballarín J
    Nefrologia; 2016; 36(6):597-608. PubMed ID: 27595517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular calcification in end-stage renal disease patients.
    Nitta K; Ogawa T
    Contrib Nephrol; 2015; 185():156-67. PubMed ID: 26023025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Kidney and bone update : the 5-year history and future of CKD-MBD. Bisphosphonates treatment for chronic kidney disease-mineral and bone disorder].
    Mori H; Okada Y; Tanaka Y; Hashimoto O
    Clin Calcium; 2012 Jul; 22(7):1034-42. PubMed ID: 22750936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vascular calcification in chronic kidney disease].
    Battaglia Y; Russo L; Asimakopoulos G; Storari A
    G Ital Nefrol; 2014; 31(3):. PubMed ID: 25030018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Bisphosphonates in Vascular calcification and Bone Metabolism: A Clinical Summary.
    Dayanand P; Sandhyavenu H; Dayanand S; Martinez J; Rangaswami J
    Curr Cardiol Rev; 2018; 14(3):192-199. PubMed ID: 29921207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular calcification in chronic kidney disease: a review.
    de Oliveira RB; Okazaki H; Stinghen AE; Drüeke TB; Massy ZA; Jorgetti V
    J Bras Nefrol; 2013; 35(2):147-61. PubMed ID: 23812573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Arterial media calcification: from pathogenesis to diagnosis].
    Marinelli A; Pistolesi V; Della Grotta F; Di Napoli A
    G Ital Nefrol; 2013; 30(4):. PubMed ID: 24403195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An update on vascular calcification and potential therapeutics.
    Singh A; Tandon S; Tandon C
    Mol Biol Rep; 2021 Jan; 48(1):887-896. PubMed ID: 33394226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vascular calcification and arteriosclerosis in chronic kidney disease patients].
    Rodríguez Portillo JM
    Med Clin (Barc); 2009 May; 132 Suppl 1():43-7. PubMed ID: 19460480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis and clinical implications of vascular calcification of chronic kidney disease in Mexico].
    Bañuelos-Chávez KV; Cerrillos-Gutiérrez JI; Nario JC; Abundis-Jiménez J; Preciado-Rojas P; Campos-Mariz A; Cortés-Sanabria L; Cueto-Manzano AM; Rojas-Campos E
    Rev Med Inst Mex Seguro Soc; 2017; 55(Suppl 2):S151-7. PubMed ID: 29697236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging for Vascular Calcification.
    Raggi P; O'Neill WC
    Semin Dial; 2017 Jul; 30(4):347-352. PubMed ID: 28332217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical imaging of vascular disease in chronic kidney disease.
    Sag AA; Covic A; London G; Vervloet M; Goldsmith D; Gorriz JL; Kanbay M
    Int Urol Nephrol; 2016 Jun; 48(6):827-37. PubMed ID: 26898824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atherosclerotic ischemic renal disease: clinical challenges].
    Robles NR
    Med Clin (Barc); 2015 Feb; 144(4):163-5. PubMed ID: 25433792
    [No Abstract]   [Full Text] [Related]  

  • 17. Role of hyperphosphatemia-mediated vascular calcification in cardiovascular outcomes and its management: a review.
    Latif F; Khalid MM; Khan F; Omar Z; Ali FA
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):410-5. PubMed ID: 23392553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards a better understanding of arterial calcification disease progression in CKD: investigation of early pathological alterations.
    Van den Bergh G; Opdebeeck B; Neutel C; Guns PJ; De Meyer G; D'Haese P; Verhulst A
    Nephrol Dial Transplant; 2023 May; 38(5):1127-1138. PubMed ID: 36316014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Addition of Vascular Calcification Scores to Traditional Risk Factors Improves Cardiovascular Risk Assessment in Patients with Chronic Kidney Disease.
    Liabeuf S; Desjardins L; Diouf M; Temmar M; Renard C; Choukroun G; Massy ZA
    PLoS One; 2015; 10(7):e0131707. PubMed ID: 26181592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between magnesium and clinical biomarkers on inhibition of vascular calcification.
    Salem S; Bruck H; Bahlmann FH; Peter M; Passlick-Deetjen J; Kretschmer A; Steppan S; Volsek M; Kribben A; Nierhaus M; Jankowski V; Zidek W; Jankowski J
    Am J Nephrol; 2012; 35(1):31-9. PubMed ID: 22179063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.